Good Bacteria Enter a Baby's Digestive System Through

Curr Opin Pediatr. Author manuscript; available in PMC 2012 Apr 1.

Published in final edited form as:

PMCID: PMC3155417

NIHMSID: NIHMS297443

THE Intestinal MICROBIOME OF INFANTS AND THE Use OF PROBIOTICS

Flavia Indrio

Academy of Bari, Bari, Italia

Josef Neu

University of Florida, Gainesville, Florida, Us

Abstract

Purpose of the review

The increasing employ of probiotics in neonates deserves scrutiny of the therapeutic also as potentially harmful furnishings of these bacteria. In this review we describe the possible application of probiotics in the more than mutual disease in the neonatal period.

Recent finding

Contempo advances our capability to place microbes and their role in the gastrointestinal tract offer exciting opportunities to discover the pathophysiology of enigmatic diseases such as necrotizing enterocolitis (NEC) and belatedly onset sepsis (LOS) in the neonate. The relationship of the resident intestinal microbes to neural and muscular processes such as intestinal motility and neurodevelopment are also being evaluated.

Summary

We focus the possibility of the application of probiotics for disorders of motility in the babe, NEC and LOS Here we will summarize some of the recent advances in these areas equally they relate to clinical exercise and discuss areas where boosted enquiry is needed.

Keywords: Abdominal Microbiota, intestinal mucosa-neural– microbiota interactions, microbial components upshot on intestine

INTRODUCTION

Interactions of resident intestinal microbes with the luminal contents and the mucosal surface play important roles in normal intestinal development, diet and immunity. The intestine has a big and also frail surface surface area covered by a thin monolayer of multifunctional epithelial cells that overlies a highly immunoreactive submucosa. During health, interactions in the lumen between resident microbes, nutrients and the intestinal mucosa promote intestinal development also as the immune system.(i)Disruption of this bulwark may have numerous detrimental consequences including systemic inflammation, autoimmune and allergic disorders. Evidence is apace emerging that supports the being of a brain-gut-intestinal microbiota axis in which specialized abdominal epithelial cells serve as signaling intermediates to neuronal circuits. This has of import implications in motility, an of import factor in feeding tolerance for neonates, likewise equally the pathophysiology of astute and chronic gastrointestinal diseases. (ii)

Recent advances in molecular microbiota analytic methodology that stems from advances in high throughput sequencing technology take provided u.s.a. with the tools to decide the taxonomy of intestinal microbiota in great depth, including the nigh 80% of microbes in the intestine that are very difficult if not impossible to culture by current methodology.(three) In the preterm neonate, application of these techniques to derive a better understanding of the developing intestinal ecosystem may aid enhance enteral nutrition and prevent several important diseases including necrotizing enterocolitis (NEC) and late onset neonatal sepsis. This review will provide a brief summary of current knowledge of the developing intestinal microbiota in the term and preterm infant and provide an overview of the interactions of the microbiota and intestinal mucosa and how these interactions may alter physiologic phenomena such equally motility, feeding intolerance necrotizing enterocolitis and late onset sepsis.

DEVELOPMENT OF THE Abdominal MICROBIOTA IN THE PREMATURE Babe

The GI tract of a normal fetus is generally idea to be sterile. Still, recent studies are suggesting that the fetal intestine may be exposed to microbes via swallowing of colonized amniotic fluid.(4) This remains a largely unexplored area. Nonetheless, during the birth process and rapidly thereafter, microbes from the female parent and the surrounding environment colonize the alimentary canal of the infant,(five) eventually leading to a dense and diverse bacterial community.(6)

Whether the infant is born prematurely and requires intensive care or is a term infant who is built-in without special needs could markedly affect the development of the intestinal microbial core. Although several studies have monitored the bacterial communities in preterm infants, our picture of the microbiota yet remains express; primarily because primarily express civilisation-based techniques have been previously used. Information technology is non known whether prematurity itself may influence the abdominal establishment of microbiota. Many preterm infants require intensive intendance procedures early in life, which may be one of the major factors determining intestinal microbiota development. Many preterm infants receive antibiotics for ill-divers criteria, which are thought to have an influence of bacterial colonization.

In a study that used microbiota profiles adamant in 22 infants with denaturing gradient gel electrophorises (DGGE), unique compositions for each babe were revealed. Although composition inverse with time, characteristic bands were observed for each infant at multiple times. At that place was a trend toward increased multifariousness with time. No significant associations were detected between microbiota diversity and sexual practice, nascency weight, gestational age, prolonged rupture of membranes, maternal intrapartum antibiotics, or way of delivery when the microbiota were evaluated after the first week of life, although differences were constitute in meconium samples collected in the first week after nativity in terms of intent to breast feed versus formula feed, maternal antibiotic usage and gestational historic period at commitment.(vii) This study likewise employed a technique that was limited in terms of in-depth taxonomic evaluation. As whole genome sequencing and metagenomic techniques become available and less expensive, the likelihood of a more comprehensive analysis increases.

INTERACTIONS OF THE MICROBIOTA AND THE INTESTINAL Barrier

The gut-barrier is presented with a major challenge; preventing luminal pathogens and harmful substances from entering into the internal milieu and yet promoting digestion and dissimilar architectural units of this barrier. Exposed to trillions of luminal microbes, the intestinal mucosa averts threats by signaling to the innate immune system, through blueprint recognition receptors, to respond to the commensal bacteria past developing tolerance (hyporesponsiveness) towards them. This organisation besides acts by protecting against pathogens past elaborating and releasing protective peptides, cytokines, chemokines, and phagocytic cells. The abdominal mucosa is constantly sampling luminal contents and making molecular adjustments at its frontier. Some of the details of this bulwark role are provided in other recent reviews and are beyond the scope of this review. (8, ix)

The Enteric Nervous System and Interaction with Intestinal Microbes: Role in Motility

Brain–abdominal interactions are well known mechanisms for the regulation of abdominal role in both healthy and diseased states. A role of the enteric microbes in these interactions has only been recognized in the past few years. The brain can influence commensal organisms via changes in gastrointestinal motion, secretion, and abdominal permeability, or directly, via signaling molecules released into the gut lumen from cells in the lamina propria (enterochromaffin cells, neurons, allowed cells).(two) Enteric microbiota advice occurs via epithelial-cell, receptor-mediated signaling and, when intestinal permeability is increased, through direct stimulation of host cells in the lamina propria. Integral to these communications are enterochromaffin cells, which serve as bidirectional transducers that regulate advice betwixt the intestinal lumen and the nervous system. Disruption of the bidirectional interactions between the enteric microbiota and the nervous organization may exist involved in the pathophysiology of acute and chronic gastrointestinal disease states, including functional and inflammatory bowel disorders. (2)

Commensal bacteria inhabiting the human intestine participate in the evolution and maintenance of gut sensory and motor functions, including the promotion of intestinal propulsive activity. On the other hand, abdominal movement represents one of the major control systems of gut microflora, through the removal of excessive leaner from the lumen. Under normal conditions, the gastrointestinal tract provides a stable habitat for commensal bacteria that supports its structural and functional integrity. Disturbance of normal GI physiology destabilizes the habitat, resulting in changes in its microbial limerick. Alternatively, changes in the microbiota, induced by infection or antibiotics, or other events such as stress, perturb physiologic inflammation and gut physiology. (2)

Normal intestinal motility requires the coordination between the extrinsic neurons, enteric motor neurons, interstitial cells of Cajal (ICC) and polish musculus cells (SMC). The enteric nervous organisation (ENS) is a circuitous integrative brain (too called the second brain) which is capable of controlling the GI role. The ENS influences the gut directly with the action related to the contraction (SMS ICC) and indirectly influencing the cells of the gut immune arrangement and the epithelial cells. This interaction is bidirectional and relies on the mechanisms of neuroimmune interaction, which involves bacterial component activation of Toll-like and other bacterial molecular pattern receptors to trigger innate immune responses and the intestinal neural pathways.

The abdominal microbiota is involved in the development and maintenance of gut sensory and motor functions past the release of bacterial substances, fermentation products and intestinal neuroendocrine factors, and through a close link with the gastrointestinal immune arrangement. (10, 11) The end-products of colonic microbiota fermentation, the curt-chain fat acids (SCFAs), may modulate lower and upper gut motor events via direct and probably via indirect (nervous) pathway. The interplay among all these systems and apparatus is central for the appropriate function of the gut every bit depicted in Fig ane.

NEUROIMMUNE INTERACTION AND MICROBIOTA

Commensal bacteria inhabiting the human being intestine (i.due east., intestinal microflora) participate in the development and maintenance of gut sensory and motor functions, including the promotion of abdominal propulsive activity. Normal intestinal motility requires the coordination between, enteric motor neurons ICC and polish muscle cells. The ENS influences the gut directly with the activity related to the contraction (SMC ICC ) and indirectly influencing the cells of the gut immune system. The functional bidirectional interaction act via neuroimmune peptide receptor on allowed cells and on several receptor for immune mediators expressed on enteric nerves. Immune cells release mediators (cytokines, prostanoids) in response to neural stimuli Enteric and sensory nerves answer to immune stimuli

Several studies in animals have evaluated the direct effect of private probiotics on gastrointestinal motion (Table 1). Of interest is the finding that microbes do non need to be alive to exert an effect. One study aimed explored the effects of live, heat killed, or gamma irradiated Lactobacillus reuteri (50. reuterii) on cardio-autonomic response and unmarried fiber unit discharge in dorsal root ganglia to colorectal amplification in healthy Sprague-Dawley rats housed under conventional conditions. (12)Handling with live, heat killed, or gamma irradiated leaner besides as their products (conditioned medium) prevented the pain response even during the maximum distension force per unit area at lxxx mm Hg.

TABLE 1

In vivo studies demonstrating the outcome of specific strain of probiotic on intestinal motility and visceral perception

Study	Probiotic strain	Effect
Kamiya T el al (12)	L. reuterii ATCC 23272	Inhibited cardioautonomic response to colorectal distension
Rousseaux C et al (13)	Lactobacillus acidofilus NCFM	Analgesic effect inducing expression of n-oppiod and cannabinoid receptor in intestinal epithelial cells
Ma Ten et al (xiv)	L. reuterii (non specified strain)	Forbid hyperexcitability of colonic DRG neurons induced by baneful stimuli
Wang B et al (15)	L. reuterii ATCC 23272	Enhancing tonic inhibition of colon contractile activity past acting via the IKCa channel current in AH cells

Rosseaux, et al. (13) reported that oral assistants of specific Lactobacillus strains (NCFM) induced the expression of fifty-opioid and cannabinoid receptors in abdominal epithelial cells, and mediated analgesic functions in the gut, similar to the effects of morphine. This analgesic effect was enhanced equally the NCFM dosage was increased from 10^seven CFU/d to 10⁹ CFU/d and disappeared 3 d after the terminal NCFM administration. Another study aimed to make up one's mind whether dorsal root ganglion (DRG) somas could be a locus where the antinociceptive probiotic may take an result.(14) Healthy rats were fed with Fifty. reuterii or vehicle control for 9 days whereupon they were anesthetized, and intermittent distal colonic colorectal distention (CRD) at 80 mmHg distension was either performed for ane h or not. The animals were immediately euthanized and patch-clamp recordings taken after isolation and overnight civilisation from those DRG that projected to the distal colon. CRD decreased the threshold for activeness potential generation and increased the number of spikes discharged during a standard depolarizing test stimulus, and this effect was blocked past prior probiotic ingestion.

The same group one year afterward elucidated the neuronal machinery of activeness of L. reuterii.(15) In this report 50. reuterii ingestion alters the motility of the colon segment. decrease the amplitude of wrinkle at constant luminal pressure and increase the threshold of luminal pressure level required to evoke rhythmic contraction.

50. reuterii partially blocked the intermediate conductance calcium dependent potassium aqueduct (IKCa) of AH myenteric neurons.

The major clinical disorders in newborn where the effect of probiotic on gastrointestinal motility have been studied include feeding intolerance, regurgitation, colic and constipation. These are of import subject of study for pediatricians and all those diseases might do good from dietary handling. A randomized, double blind study demonstrated the beneficial effects of probiotics on clinical and physiological parameters(sixteen). In this study gastrointestinal movement was recorded every bit a measure out of gastric electrical activity, measure of the wall movements, and measure of gastric emptying time. The authors demonstrated that amplitude and percent of normal slow waves, bradygastria, and tachygastria did not differ in the three groups of preterm newborns. As regard gastric emptying time, a smaller fasting antral area was found in preterm fed with formula added with 50. reuterii compared to that one fed with formula with placebo and newborns fed with chest milk.. Furthermore, the gastric emptying rate was significantly faster in formula added with probiotics group respect to chest milk and formula plus placebo. In particular it shows that oral probiotic( L. reuterii )supplementation in preterm newborns improves feeding tolerance, reduces the crying time and increase stool frequency. Taken together these findings back up that this amanuensis reduces gastric residual in newborns.

POSSIBLE ROLE OF Abdominal MICROBIOTA IN NECROTIZING ENTEROCOLITIS (NEC)

Necrotizing enterocolitis (NEC) is a devastating disease affecting primarily premature infants. Despite advances in neonatal care, the mortality charge per unit following NEC has not changed significantly in the past 30 years. Information technology remains an enigmatic and potentially devastating condition with high morbidity and mortality in preterm infants. Although the etiology of NEC remains unknown, initial bacterial colonization could play a pivotal role in the development of NEC. Sequencing studies have demonstrated that sequences from NEC patients cluster separately from sequences from control patients. (17) In this study, the microbial customs construction in NEC patients (during the time of NEC and antibiotic use) was singled-out based on a pregnant decrease in diverseness of microbial species with an increment in Proteobacteria dominance compared to other preterm infants. In another study, (seven)microbiota compositions were compared in 6 preterm infants in whom NEC, signs of systemic inflammation, or both developed with matched command subjects past using 16S ribosomal RNA pyrosequencing. In samples taken approximately one week prior to the evolution of NEC, a 16S ribosomal RNA sequence analysis detected Citrobacter-similar sequences only in cases with NEC (three of 4) and a tendency toward increased frequency of Enterococcus-like sequences in cases and Klebsiella in command subjects. The overall microbiota profiles in cases with NEC were non distinguishable from that in control subjects. More studies using similar technologies are required to establish a relationship between specific microbes or microbial patterns and NEC.

PROBIOTICS AND NEC and Late Onset Sepsis (LOS)

Probiotics are microbial strains of human origin, non-pathogenic, adherent to gut epithelium, colonize the intestinal tract, produce antimicrobial substances and modulate immune responses. It is hypothesized that probiotics act to downregulate pathogenic organisms and protect confronting abdominal inflammation. The lack of adequate colonization in the preterm neonate could identify them at an increased take a chance for neonatal NEC. (18)Therefore, several clinical studies have been performed in premature infants to evaluate the safety and efficacy of probiotic supplementation. A recent meta-assay suggested efficacy. (19)

Despite these promising initial results, several questions remain that preclude their use as a standard of care for preterm infants. Beginning, there are several species that have been utilized in the various studies, all of which have diverse effects, and the optimal preparation has not been clarified. In addition to the species, little is known regarding optimal dose, dosing strategy and whether live or adulterate probiotics are optimal for this condition. Furthermore, it is suggested that gut colonization with these organisms is important, yet no studies have confirmed that agile colonization is necessary for disease prevention. Most importantly, additional information is needed to confirm that this arroyo is safe in this loftier-risk population. Although over chiliad preterm infants take been supplemented, the preparations have differed in the specificity of organism, and there is fiddling federal regulation of probiotics when marketed as nutrient additives. This federal regulation is needed as studies have shown that some preparations exercise non contain the active probiotics reported, and others accept pathogenic organisms in the preparation. Finally, long-term effects of this approach should be evaluated, as these organisms tin can alter immune responses and microbial–epithelial cross talk, and therefore could upshot in many long-term effects. However, probiotics are a promising arroyo for the prevention of neonatal NEC, and forthcoming studies may confirm the safe and efficacy.

CONCLUSIONS

The intestine serves as a vast interface between our internal and external environments. Show is rapidly accumulating that the microbes residing within the intestinal tract play major roles in the development of the allowed arrangement, and interact with the abdominal as well equally central nervous systems. The implications of these interactions in health and disease are condign increasingly evident and in some cases manipulations of the microbial ecosystems advise significant do good. Nigh of the studies to date using probiotics to manipulate the intestinal microbiota and to prevent or treat disease have been empiric and much more needs to be learned about the indigenous flora and their interactions with the developing intestinal tract before nosotros tin can be comfortable in routinely manipulating the abdominal microbial ecosystem.

Acknowledgments

Dr Neu is on the Mead Johnson and Medela Scientific Advisory Boards, and has a grant with Mead Johnson and NIH

Contributor Data

Flavia Indrio, University of Bari, Bari, Italy.

Josef Neu, Academy of Florida, Gainesville, Florida, U.s..

References

1. Loma DA, Artis D. Intestinal leaner and the regulation of immune cell homeostasis. Annu Rev Immunol. 2010 Mar;28:623–67. [PMC gratuitous article] [PubMed] [Google Scholar]

2. Rhee SH, Pothoulakis C, Mayer EA. Principles and clinical implications of the brain-gut-enteric microbiota centrality. Nat Rev Gastroenterol Hepatol. 2009 May;6(5):306–fourteen. [PMC gratuitous article] [PubMed] [Google Scholar]

3. Hattori M, Taylor TD. The human intestinal microbiome: a new frontier of human biology. DNA Res. 2009 February;xvi(one):1–12. [PMC gratis commodity] [PubMed] [Google Scholar]

four** DiGiulio DB, Romero R, Amogan HP, Kusanovic JP, Bik EM, Gotsch F, et al. Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and civilization-based investigation. PLoS ONE. 2008 Aug 26;3(8):33056. Provide information that suggests that occult microbes in amniotic fluid may exist associated with preterm labor. These raise several hypotheses as to the mechanisms of this action. [PMC gratis article] [PubMed] [Google Scholar]

5. Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo Chiliad, Fierer N, et al. Delivery manner shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U South A. 2010 jun 29;107(26):11971–five. [PMC free commodity] [PubMed] [Google Scholar]

6. Palmer C, Bik EM, Digiulio DB, Relman DA, Brown PO. Evolution of the Human Baby Intestinal Microbiota. PLoS Biol. 2007 Jun;5(7):e177. [PMC free article] [PubMed] [Google Scholar]

seven. Mshvildadze M, Neu J, Mai V. Intestinal microbiota development in the premature neonate: institution of a lasting commensal human relationship? Nutr Rev. 2008 Nov;66(11):658–63. [PubMed] [Google Scholar]

viii. Sharma R, Immature C, Neu J. Molecular modulation of intestinal epithelial barrier: contribution of microbiota. J Biomed Biotechnol. 2010 Epub 2010 Jan 31. [PMC free article] [PubMed] [Google Scholar]

9. Abreu MT. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol. 2010 Feb;10(2):131–44. [PubMed] [Google Scholar]

10. Rondeau MP, Meltzer Grand, Michel McManus KE, Washabau RJ. Brusque concatenation fat acids stimulate feline colonic smooth muscle contraction. J Feline Med Surg. 2003;5:167–73. [PubMed] [Google Scholar]

11. Cherbut C. Motor effects of brusk-chain fat acids and lactate in the gastrointestinal tract. Proc Nutr Soc. 2003;62:95–9. [PubMed] [Google Scholar]

12* Kamiya T, Wang 50, Forsythe P, Goettsche One thousand, Mao Y, Wang Y, et al. Inhibitory effects of Lactobacillus reuteri on visceral hurting induced by colorectal distension in Sprague-Dawley rats. Gut. 2006 February;55(2):191–six . Back up that oral administration of either live or killed probiotic bacteria or conditioned medium inhibited the constitutive cardio-autonomic response to colorectal distension in rats through effects on enteric nerves. Show that componets of proiitocs as well equally the probiotics themselves may have an effect on visceral hurting. [PMC free article] [PubMed] [Google Scholar]

13** Rousseaux C, Thuru X, Gelot A, Barnich Due north, Neut C, Dubuquoy L, et al. Lactobacillus acidophilus modulates intestinal hurting and induces opioid and cannabinoid receptors. Nat Med. 2007 Jan;xiii(1):35–7. Provides a review of how a specific microbe alters pain pathways in the intestine. [PubMed] [Google Scholar]

14. Ma X, Mao YK, Wang B, Huizinga JD, Bienenstock J, Kunze W. Lactobacillus reuteri ingestion prevents hyperexcitability of colonic DRG neurons induced by noxious stimuli. Am J Physiol Gastrointest Liver Physiol. 2009 April;296(iv):G868–75. [PubMed] [Google Scholar]

xv** Wang B, Mao YK, Diorio C, Wang L, Huizinga JD, Bienenstock J, Kunze Westward. Lactobacillus reuteri ingestion and IK(Ca) channel blockade have similar furnishings on rat colon motility and myenteric neurones. Neurogastroenterol Motil. 2010 Jan;22(1):98–107 . These 2 studies (#14 and 15) provide prove for a rapid, strain-specific, dose-dependent activeness of a live Lactobacillus on colonic motility. These observations suggest mechanisms to unraveling the pathways involved in leaner to the nervous system advice. [PubMed] [Google Scholar]

16* Indrio F, Riezzo G, Raimondi F, Bisceglia M, Cavallo Fifty, Francavilla R. The furnishings of probiotics on feeding tolerance, bowel habits, and gastrointestinal motility in preterm newborns. J Pediatr. 2008 Jun;152(6):801–6. This written report is the first written report in newborn that demonstrate a change in a physiological function by a probiotic. [PubMed] [Google Scholar]

17. Wang Y, Hoenig JD, Malin KJ, Qamar S, Petrof EO, Sun J, et al. 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J. 2009 Aug;3(viii):944–54. [PMC free article] [PubMed] [Google Scholar]

18. Caplan MS. Probiotic and prebiotic supplementation for the prevention of neonatal necrotizing enterocolitis. Journal of Perinatology. 2009 May;29:S2–S6. [PubMed] [Google Scholar]

xix. Deshpande K, Rao Southward, Patole S, Bulsara Grand. Updated Meta-analysis of Probiotics for Preventing Necrotizing Enterocolitis in Preterm Neonates. Pediatrics. 2010 Apr nineteen; [PubMed] [Google Scholar]

williamsgrayoucand.blogspot.com

Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155417/